Hall B M, Fava L, Chen J, Plain K M, Boyd R A, Spicer S T, Berger M F
Department of Medicine, University of New South Wales, Liverpool Hospital, New South Wales, Australia.
J Immunol. 1998 Nov 15;161(10):5147-56.
Anti-CD4 mAb-induced tolerance to transplanted tissues has been proposed as due to down-regulation of Thl cells by preferential induction of Th2 cytokines, especially IL-4. This study examined the role of CD4+ cells and cytokines in tolerance to fully allogeneic PVG strain heterotopic cardiac allografts induced in naive DA rats by treatment with MRC Ox38, a nondepleting anti-CD4 mAb. All grafts survived >100 days but had a minor mononuclear cell infiltrate that increased mRNA for the Thl cytokines IL-2, IFN-gamma, and TNF-beta, but not for Th2 cytokines IL-4 and IL-6 or the cytolytic molecules perforin and granzyme A. These hosts accepted PVG skin grafts but rejected third-party grafts, which were not blocked by anti-IL-4 mAb. Cells from these tolerant hosts proliferated in MLC and produced IL-2, IFN-gamma, and IL-4 at levels equivalent to naive cells. Unfractionated and CD4+ T cells, but not CD8+ T cells, transferred specific tolerance to irradiated heart grafted hosts and inhibited reconstitution of rejection by cotransferred naive cells. This transfer of tolerance was associated with normal induction of IL-2 and delayed induction of IFN-gamma, but not with increased IL-4 or IL-10 mRNA. Transfer of tolerance was also not inhibited by anti-IL-4 mAb. This study demonstrated that tolerance induced by a nondepleting anti-CD4 mAb is maintained by a CD4+ suppressor T cell that is not associated with preferential induction of Th2 cytokines or the need for IL-4; nor is it associated with an inability to induce Th1 cytokines or anergy.
抗CD4单克隆抗体诱导的对移植组织的耐受性被认为是由于通过优先诱导Th2细胞因子,特别是IL-4,使Th1细胞下调。本研究检测了CD4+细胞和细胞因子在未致敏的DA大鼠中由非清除性抗CD4单克隆抗体MRC Ox38诱导的对完全同种异体PVG品系异位心脏移植耐受性中的作用。所有移植心脏存活超过100天,但有少量单核细胞浸润,其增加了Th1细胞因子IL-2、IFN-γ和TNF-β的mRNA表达,但未增加Th2细胞因子IL-4和IL-6或细胞溶解分子穿孔素和颗粒酶A的mRNA表达。这些宿主接受PVG皮肤移植,但排斥第三方移植,且这种排斥未被抗IL-4单克隆抗体阻断。来自这些耐受宿主的细胞在混合淋巴细胞培养中增殖,并产生与未致敏细胞水平相当的IL-2、IFN-γ和IL-4。未分离的和CD4+ T细胞,而不是CD8+ T细胞,将特异性耐受性转移至接受心脏移植的受照射宿主,并抑制共转移的未致敏细胞重建排斥反应。这种耐受性转移与IL-2的正常诱导和IFN-γ的延迟诱导有关,但与IL-4或IL-10 mRNA的增加无关。耐受性转移也未被抗IL-4单克隆抗体抑制。本研究表明,非清除性抗CD4单克隆抗体诱导的耐受性由CD4+抑制性T细胞维持,该细胞与Th2细胞因子的优先诱导或对IL-4的需求无关;也与诱导Th1细胞因子的无能或无反应性无关。